These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 33109219

  • 1. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y, Zheng R, Li J, Feng S, Wang L, Huang Z.
    Lipids Health Dis; 2020 Oct 28; 19(1):229. PubMed ID: 33109219
    [Abstract] [Full Text] [Related]

  • 2. [Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease].
    Xiao J, Li Y, Fang M, Gong H, Li W, Zhang C, Chen F, Zhang Y, Han T.
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul 20; 44(7):1266-1271. PubMed ID: 39051072
    [Abstract] [Full Text] [Related]

  • 3. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H, Han Y, Cao C, He Y.
    J Transl Med; 2022 Sep 05; 20(1):398. PubMed ID: 36064712
    [Abstract] [Full Text] [Related]

  • 4. Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Zhang F, Han Y, Wu Y, Bao Z, Zheng G, Liu J, Li W.
    Ann Med; 2024 Dec 05; 56(1):2409342. PubMed ID: 39348274
    [Abstract] [Full Text] [Related]

  • 5. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y.
    Lipids Health Dis; 2021 Oct 10; 20(1):134. PubMed ID: 34629059
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
    Wang R, Dai L, Zhong Y, Xie G.
    Lipids Health Dis; 2021 Jul 28; 20(1):77. PubMed ID: 34321005
    [Abstract] [Full Text] [Related]

  • 7. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S, Feng L, Ding J, Zhou W, Yuan T, Mao J.
    BMC Gastroenterol; 2023 Nov 02; 23(1):376. PubMed ID: 37919650
    [Abstract] [Full Text] [Related]

  • 8. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
    Zhang S, Du T, Li M, Jia J, Lu H, Lin X, Yu X.
    Medicine (Baltimore); 2017 Jun 02; 96(22):e7041. PubMed ID: 28562560
    [Abstract] [Full Text] [Related]

  • 9. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Li N, Tan H, Xie A, Li C, Fu X, Xang W, Kirim A, Huang X.
    BMC Endocr Disord; 2022 Apr 15; 22(1):101. PubMed ID: 35428219
    [Abstract] [Full Text] [Related]

  • 10. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F.
    Metab Syndr Relat Disord; 2021 Apr 15; 19(3):167-173. PubMed ID: 33259744
    [Abstract] [Full Text] [Related]

  • 11. Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study.
    Wang X, Liu J, Cheng Z, Zhong Y, Chen X, Song W.
    Lipids Health Dis; 2021 Sep 06; 20(1):99. PubMed ID: 34488806
    [Abstract] [Full Text] [Related]

  • 12. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
    Zeng P, Cai X, Yu X, Gong L.
    Sci Rep; 2023 Nov 22; 13(1):20470. PubMed ID: 37993481
    [Abstract] [Full Text] [Related]

  • 13. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
    Kilonzo SB, Kamala E, Jaka H, Ngoya P.
    BMC Gastroenterol; 2024 Mar 04; 24(1):96. PubMed ID: 38438930
    [Abstract] [Full Text] [Related]

  • 14. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
    He X, Huang X, Qian Y, Sun T.
    Front Endocrinol (Lausanne); 2023 Mar 04; 14():1188214. PubMed ID: 37484966
    [Abstract] [Full Text] [Related]

  • 15. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M.
    Can J Gastroenterol Hepatol; 2019 Mar 04; 2019():5121574. PubMed ID: 31687367
    [Abstract] [Full Text] [Related]

  • 16. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
    Otsubo N, Fukuda T, Cho G, Ishibashi F, Yamada T, Monzen K.
    Intern Med; 2023 Aug 15; 62(16):2307-2319. PubMed ID: 36517035
    [Abstract] [Full Text] [Related]

  • 17. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, Yang Y, Yu X.
    Lipids Health Dis; 2017 Jan 19; 16(1):15. PubMed ID: 28103934
    [Abstract] [Full Text] [Related]

  • 18. Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study.
    Wang Y, Wang J, Liu L, Yang P, Deng S, Liu X, Zhao L, Wang C, Li Y.
    Front Endocrinol (Lausanne); 2023 Jan 19; 14():1137098. PubMed ID: 37223043
    [Abstract] [Full Text] [Related]

  • 19. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China.
    Huanan C, Sangsang L, Amoah AN, Yacong B, Xuejiao C, Zhan S, Guodong W, Jian H, Songhe S, Quanjun L.
    BMJ Open; 2020 Nov 27; 10(11):e039804. PubMed ID: 33247011
    [Abstract] [Full Text] [Related]

  • 20. Association between TyG index and risk of carotid atherosclerosis in NAFLD patients: a retrospective cohort study.
    Huang W, Wang H, Shen Z, Wang X, Yu X.
    Front Endocrinol (Lausanne); 2024 Nov 27; 15():1448359. PubMed ID: 39229376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.